Warning Letter Should Not Hinder Taxus Liberté Approval – Boston Scientific

Boston Scientific estimates it will be ready by June for FDA to re-inspect its facilities to confirm that the quality-control problems cited in a sweeping Jan. 25 warning letter have been fixed